Core Insights - Atea Pharmaceuticals is hosting a virtual Key Opinion Leader (KOL) event focused on hepatitis C, featuring leading experts in hepatology and infectious diseases [2][3]. Company Overview - Atea Pharmaceuticals is led by Dr. Jean-Pierre Sommadossi, who serves as the Founder, Chairman, and CEO [2]. - The company aims to discuss the commercial market opportunity for hepatitis C virus (HCV) treatments during the event [3]. Expert Panel - The event includes a panel of experts from notable institutions, such as Dr. Jordan Feld from the University of Toronto, Dr. Eric Lawitz from the Texas Liver Institute, Dr. Anthony Martinez from the University of Buffalo, and Nancy Reau from Rush University Medical Center [3]. - Atea's Chief Commercial Officer, John Vavricka, along with other key executives, will present insights on the HCV market and treatment profiles [3].